28 articles in Tirzepatide, page 1 of 3
Newest first
The two leading GLP-1 weight loss medications compared at the molecule level. Mechanism, clinical-trial efficacy, side effects, cost, cardiovascular outcomes, and the framework Harbor's clinical team uses to choose between them.
By Harbor Health Team
Zepbound is brand-name tirzepatide for weight loss. Compounded tirzepatide is the same molecule prepared differently. The choice in 2026 comes down to cost, insurance coverage, and tolerance for the trade-offs of each path. Written by Harbor's medical team.
By Harbor Health Team
Two FDA-approved weight loss injections from competing manufacturers, compared on every metric that matters in 2026. Mechanism, trial-grade efficacy, side effects, real cost, and how to choose, by Harbor's medical team.
By Harbor Health Team
Mounjaro and compounded tirzepatide contain the exact same active ingredient. The differences are FDA label, manufacturer, cost, and regulatory framework. Here's the honest breakdown from Harbor's medical team.
By Harbor Health Team
A side-by-side clinical comparison of tirzepatide and Ozempic for weight loss. Mechanism, trial-grade efficacy, side effects, real cost in 2026, and exactly how to switch, by Harbor's medical team.
By Harbor Health Team
Tirzepatide's dosing schedule is one of the most important aspects of treatment that patients need to understand before starting the medication.
By Harbor Health Team
For the estimated 37 million Americans living with type 2 diabetes, the relationship between blood sugar management and weight loss has always been frustratingly circular: excess weight drives insulin resistance, insulin resistance makes weight loss harder, and many diabetes medications actually cause weight gain as a side effect.
By Harbor Health Team
"How much weight will I lose?" is the first question most patients ask when considering tirzepatide, and it deserves a thorough, evidence-based answer.
By Harbor Health Team
Tirzepatide's dosing schedule is one of the most important aspects of treatment that patients need to understand before starting the medication.
By Harbor Health Team
Tirzepatide is the first medication in its class to target two incretin hormones simultaneously - GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).
By Harbor Health Team
For decades, heart failure with preserved ejection fraction has been one of cardiology's most frustrating puzzles.
By Harbor Health Team
Tirzepatide changes the way your body communicates hunger, fullness, and blood sugar regulation.
By Harbor Health Team
